FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/07/2026
Voltar para busca
Dado oficial do USPTO
BIO CITY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
09/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
10/09/2024
Data de registro
09/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
09/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
LT
Examinador
KAJUBI, ELIZABETH N
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the literal element BIO CITY appears in orange on a black background. The "O" element of the word "BIO" is stylized to have two curved lines emanating from above and below the letter.
Titulares e representantes
Titulares
UAB "Northway turto valdymas"
Representantes
John Zaccaria Notaro, Michalos & Zaccaria P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; chemical preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19.
Classe 42
Scientific and technological services and research and design relating thereto, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; Scientific research in the nature of conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technological research in the field of development of manufacturing processes for biotechnology products for pharmaceutical use; technological consultancy in the field of development of manufacturing processes for biotechnology products
Classe 44
Medical services; alternative medicine services; in vitro fertilization services; occupational therapy services; human tissue bank services; rental of medical equipment; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/06/2026
FIMP
FINAL DISPOSITION PROCESSED
21/06/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/06/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/06/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/10/2025
PUBO
PUBLISHED FOR OPPOSITION
21/10/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/09/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/09/2025
RFNT
REFUSAL PROCESSED BY IB
17/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/04/2025
RFRR
REFUSAL PROCESSED BY MPU
27/04/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/03/2025
CNRT
NON-FINAL ACTION WRITTEN
14/03/2025
DOCK
ASSIGNED TO EXAMINER
11/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
21/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/01/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
21/01/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIO CITY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.